Morphine Sulfate (MITIGO), 5 mg/mL intrathecal, 40 mL per syringe. Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901
Published March 18, 2020 · Recall initiated: February 24, 2020
Summary
FDA records drug Class II recall D-1011-2020, published March 18, 2020 and initiated February 24, 2020. Recalling firm: Redline Pharmacy Solutions; Status: Terminated; Reported quantity: 1 40 ml syringe; Lot: Lot 02242020@14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack Of Processing Controls
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Redline Pharmacy Solutions
- Distributor
- Sold to patients in Nebraska
- Lot
- Lot 02242020@14
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADaptomycin, 500MG in 0.9% NACL 100ML Injectable Redline Specialty Pharmacy, 2415 Osborne Drive E, #100March 18, 2020
- FDAMorphine Sulfate, 20 mg/mL intrathecal, 20 mL per syringe. Redline Specialty Pharmacy, 2415 Osborne Drive E,March 18, 2020
- FDAVancomycin 900MG in 100ML 0.9% NACL Injectable, Redline Specialty Pharmacy, 2415 Osborne Drive E, #100March 18, 2020
- FDAAcetylcysteine Ophthalmic 10% Solution, 5 mL per dropper bottle (10ML). Redline Specialty Pharmacy, 2415March 18, 2020
- FDABekyree (desogestrel and ethinyl estradiol tablets USP, 0.15 mg/0.02 mg and ethinyl estradiol tablets USP,March 18, 2020
- FDAErtapenem in 100ML 0.9% NACL 1GM Injectable, Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings,March 18, 2020
Questions about this recall
Was Morphine Sulfate (MITIGO), 5 mg/mL intrathecal, 40 mL per syringe. Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901 recalled?
Yes. FDA published recall D-1011-2020 on March 18, 2020. Reported hazard: Lack Of Processing Controls
What should I do if I have this product?
Voluntary: Firm initiated · Telephone